Clinical trial
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
NCT05382637 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
- Lead sponsor
- Children's National Research Institute
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 26, 2022
- Completion date
- September 1, 2028
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.